General Public’s Perception on Dangers of Psilocybin Mushrooms Align with Science

A new study suggests that the general public’s perception of the possible harms of psilocybin mushrooms doesn’t align with drug laws. The study found that magic mushrooms were considered to be less dangerous in comparison with tobacco, alcohol and other substances. The study was published in the “Journal of Psychopharmacology.”

The study’s author, professor Carl Roberts from the department of psychology at the University of Liverpool, stated that he was greatly interested in how substances affected an individual’s behavior as well as their brain. He explained that he had been following research on the therapeutic potential of psychedelic substances such as psilocybin, adding that he knew that the data on the actual harm of the use of psilocybin mushrooms proposed that the substance’s abuse potential and toxicity was low.  However, he continued, the substance was still classified as a Schedule 1 drug in the United States, which suggests that it is just as harmful as cocaine and heroin.

Roberts revealed that his interest in finding out the general public’s perception of harms around psilocybin mushrooms and whether they aligned with scientific evidence or the government’s legal classifications is what led to the study being conducted.

For their research, the researchers recruited more than 150 participants from different social media pages and websites that provide information on recreational drug use. Roughly 20% of them came from the United States while about one-half of the remaining number were from the United Kingdom. The remainder were from other countries in the European Union.

The researchers discovered that most participants considered psilocybin mushrooms to be relatively safe, in comparison with the other substances. This is despite the fact that psilocybin mushrooms are classified as a Class A substance in the U.K. and a Schedule I substance in the U.S.

The participants who had never used psilocybin listed it as the second-least dangerous substance while those who had used these mushrooms prior to the study listed it as the least dangerous substance from the list. The non-users listed marijuana as the least dangerous substance. Roberts explained that their findings proposed that the general perception of psilocybin mushroom harm aligned with scientific data on their toxicity and abuse potential as well as the relative harms of magic mushrooms that are scientifically recognized.

He notes though that the study had some limitations, including the potential of selection bias as it was an online survey style study.

That notwithstanding, the positive public perception of psilocybin means that when companies such as Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) bring to market medicines or products relating to psilocybin, the public reception is likely to be warm from the get-go.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.


Select A Month

PsychedelicNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 415.949.5050